血管内治疗后24小时颈动脉支架通畅性与结局:一项多中心研究
该多中心回顾性研究分析了2015至2019年间5个中心225例接受急性颈动脉支架置入的血管内治疗患者,20.9%在24小时内出现支架闭塞。支架通畅者3个月良好结局(改良Rankin量表0-2分)的OR为3.29(95%CI 1.66-6.52,P<0.001),死亡风险OR为0.32(95%CI 0.13-0.76,P=0.009)。卒中病因、急性期P2Y12拮抗剂使用、颅内再灌注质量和血管成形术与24小时支架通畅相关。
要点
- 急性颈动脉支架置入后24小时内支架闭塞发生率为20.9%(47/225)。
- 24小时支架通畅者3个月良好结局OR为3.29(95%CI 1.66-6.52,P<0.001)。
- 急性期使用P2Y12拮抗剂与支架通畅相关(OR 2.95,95%CI 1.10-7.91,P=0.026)。
核心结论
- 接受血管内治疗并行颈动脉支架置入的患者中,约五分之一在24小时内出现支架闭塞,该事件与更差的功能结局相关。
研究设计与样本
- 回顾性分析2015至2019年间5个高容量血管内治疗中心接受血管内治疗联合急性颈动脉支架置入的患者。
- 共纳入225例患者,按颈动脉支架置入后24小时支架是否通畅分为2组。
- 主要终点为3个月改良Rankin量表评分0-2分的良好结局。
主要发现
- 47/225例(20.9%)患者观察到支架闭塞。
- 支架通畅组基线美国国立卫生研究院卒中量表评分中位数(四分位距)为13(7-17),支架闭塞组为18(12-21)。
- 支架通畅组动脉粥样硬化血栓性卒中比例为77.0%,支架闭塞组为53.2%。
- 急性期使用P2Y12拮抗剂与支架通畅率更高相关(OR 2.95,95%CI 1.10-7.91,P=0.026)。
- 接受血管成形术与支架通畅率更高相关(OR 2.42,95%CI 1.24-4.67,P=0.008);支架通畅组颅内血管造影再灌注更好(OR 8.38,95%CI 3.07-22.78,P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Management of extracranial internal carotid artery steno-occlusive lesion during endovascular therapy remains debated. Stent occlusion within 24 hours of endovascular therapy is a frequent event after acute carotid artery stenting, and we currently lack large population results. We investigated the incidence, predictors, and clinical impact of stent occlusion after acute carotid artery stenting in current clinical practice. METHODS: Patients treated by endovascular therapy with acute carotid artery stenting between 2015 and 2019 in 5 large-volume endovascular-capable centers were retrospectively analyzed. Patients were separated in 2 groups according to the stent patency at 24 hours after carotid artery stenting. We compared baseline characteristics, treatment modalities, and clinical outcome depending on 24-hour stent patency. Primary end point was favorable outcome, defined as a modified Rankin Scale score 0-2 at 3 months. RESULTS: A stent occlusion was observed in 47/225 patients (20.9%). Patients with stent patency had a lower baseline National Institutes of Health Stroke Scale (median [interquartile range]: 13 [7-17] versus 18 [12-21]) and had more often stroke of atherothrombotic origin (77.0% versus 53.2%). A higher stent patency rate was found for patients treated with P2Y12 antagonists at the acute phase (odds ratio [OR]' 2.95 [95% CI' 1.10-7.91]; P=0.026) and treated with angioplasty (OR' 2.42 [95% CI' 1.24-4.67]; P=0.008). A better intracranial angiographic reperfusion was observed in patients with 24-hour stent patency compared with patients without stent patency (OR' 8.38 [95% CI' 3.07-22.78]; P<0.001). Patients with a stent patency at 24 hours had a higher chance of favorable outcome (OR' 3.29 [95% CI, 1.66-6.52]; P<0.001) and a lower risk of death (OR' 0.32 [95% CI, 0.13-0.76]; P=0.009). CONCLUSIONS: One out of 5 patients treated with carotid artery stenting during endovascular therapy presented a stent occlusion within 24 hours. This event was associated with worse functional outcome. Stroke etiology, P2Y12 antagonist administration, quality of intracranial reperfusion, and angioplasty were associated with 24-hour stent patency.
引用
- Allard J, Delvoye F, Pop R, et al. 24-Hour Carotid Stent Patency and Outcomes After Endovascular Therapy: A Multicenter Study. Stroke. 2022. PMID: 36542074. doi:10.1161/STROKEAHA.122.039797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。